News
How Some Surgery Practices Can Cause Post-Op Infections in Women
Women undergoing surgery face unique risks that can lead to post-op infections and prolonged recovery. Some surgical practices increase the likelihood of infections, particularly in procedures involving reproductive health, urinary health, or cosmetic enhancements.
Factors like contaminated instruments, poor hospital hygiene, and overuse of medical devices contribute to post-op complications. Women’s bodies are more vulnerable to specific bacterial infections due to anatomical differences.
Understanding these risks helps women make informed decisions about their surgical procedures. In this article, we’ll explore how certain medical practices can lead to infections and what women can do to protect their health after surgery.
Contaminated Surgical Instruments Pose High Risks
Proper sterilization of surgical instruments is crucial in preventing infections, especially for women undergoing certain procedures:
- Women undergoing hysterectomies, cesarean sections, or laparoscopic surgeries face increased risks from contaminated tools.
- Bacteria remaining on instruments can enter the body and cause severe infections.
- Women’s reproductive systems are more vulnerable to bacterial infections due to their internal structure.
- Reusing improperly sterilized surgical tools significantly raises the chances of post-op complications.
AJIC notes that sterile instruments become contaminated once opened, exposing them to operating room air and potential pathogens.
Most infections occur during surgery, but post-op contamination can happen within 24 hours from multiple sources. Poor hand hygiene and bathing introduce bacteria, increasing the risk of surgical site infections after procedures.
Medical facilities must follow strict sterilization protocols to ensure patient safety. Women should ask about a hospital’s infection control policies before undergoing any procedure. Proper instrument hygiene reduces unnecessary health risks.
How can patients ensure their hospital follows proper sterilization?
Patients can inquire about sterilization procedures and infection control practices when choosing a hospital. Requesting information on the hospital’s track record of infection rates and sterilization methods is also crucial. Ensuring the facility is accredited and follows strict hygiene guidelines helps reduce infection risks during surgery.
Hospital Environments May Contain Bacteria
Hospitals and surgical centers can harbor dangerous bacteria that increase infection risks for female patients. Women who undergo procedures in high-traffic hospitals may be more exposed to antibiotic-resistant bacteria.
WHO states that critical priority pathogens, like drug-resistant Mycobacterium tuberculosis, pose major global threats due to rising infection rates. Gram-negative bacteria resist last-resort antibiotics and spread resistance by sharing genetic material with other bacteria. Their ability to adapt quickly makes treatment difficult, increasing global healthcare burdens and limiting effective antibiotic options.
Operating rooms and recovery areas must be rigorously sanitized to prevent harmful microorganisms from spreading. Shared hospital equipment, gowns, and bedding may introduce bacteria into surgical wounds. Women recovering from gynecological or urinary surgeries are especially vulnerable to infections from hospital-acquired pathogens.
Strict hygiene measures, including frequent handwashing, reduce bacterial contamination risks. Women should choose hospitals with strong infection prevention programs. Proper sanitation protects female patients from post-op complications.
How can hospital design reduce infection transmission?
Hospital design, including isolated patient rooms and well-ventilated areas, helps reduce infection transmission. Proper airflow systems and limited patient contact with common areas can minimize bacterial spread. Hospitals are increasingly focusing on designs that reduce infection risks and provide safer environments for patients.
Temperature Control During Surgery Can Cause Infection
Maintaining body temperature during surgery reduces complications and strengthens the body’s natural infection defenses. Women undergoing long surgeries face hypothermia risks, which weaken immune responses and slow post-op healing.
Hospitals use warming methods like heated blankets, warm IV fluids, and forced-air warming devices. Temperature regulation lowers infection risks and improves surgical outcomes for women undergoing medical procedures.
Warming blankets like the Bair Hugger blanket help maintain warmth but have raised contamination concerns.
According to TruLaw, some lawsuits claim the blanket disrupts sterile fields, spreading bacteria and increasing infection risks. Studies have also suggested the risk of bacterial contamination. Women should ask doctors about alternative warming methods if they are concerned about infection risks.
The Bair Hugger lawsuit highlights the ongoing debate about the safety of warming blankets in surgical settings.
How are warming devices monitored during surgery?
Warming devices like blankets are regularly checked to ensure they are operating efficiently and safely during surgery. Medical staff monitor patient temperature and adjust these devices to maintain optimal conditions. Malfunctions or improper use of warming blankets can increase infection risks, so ongoing checks are critical.
Catheter-Related Infections Are a Big Concern for Women
Women who undergo surgery may need urinary catheters, which can introduce bacteria into the urinary tract. Female patients have a shorter urethra, making them more prone to catheter-associated urinary tract infections (UTIs).
Yale Medicine mentions that urinary tract infections (UTIs) are far more common in women than in men. The frequency of UTIs increases significantly postmenopause, although they can affect women at any age. Data shows that UTIs are a common concern across the female lifespan, requiring preventative care.
Prolonged catheter use allows bacteria to multiply, increasing infection risks after surgery. Medical staff must follow strict sterilization practices when inserting and maintaining catheters. Hydration and mobility help prevent bacterial buildup in the urinary tract during post-op recovery.
Women should ask doctors about catheter removal timelines to minimize infection risks. Proper catheter care reduces the likelihood of painful and recurring urinary tract infections after surgery.
How do UTIs impact post-surgery recovery?
UTIs can cause pain, discomfort, and additional complications, slowing recovery after surgery. In some cases, UTIs can lead to kidney infections or sepsis if left untreated. Women recovering from surgery must take precautions, such as adequate hydration, to prevent urinary tract infections and ensure a smooth recovery.
Overuse of Antibiotics Can Harm Natural Defenses
Women are often prescribed antibiotics before or after surgery to prevent infections, but overuse has consequences. Excessive antibiotic use disrupts the body’s natural balance of beneficial bacteria, increasing vulnerability to infections.
As per MedicalNewsToday, antibiotics can disrupt the gut microbiome, killing both harmful and beneficial bacteria in the process. Research shows that a balanced microbiome is crucial for digestion and overall health. Women often develop non-bacterial infections, such as yeast infections, after taking excessive antibiotics.
Women’s microbiomes are especially sensitive to antibiotic-related imbalances, leading to digestive or vaginal infections. Overprescribing antibiotics also contributes to antibiotic-resistant bacteria, making future infections harder to treat.
Hospitals with strict antibiotic protocols help reduce unnecessary prescriptions for female patients. Women should ask their doctors if antibiotics are truly necessary for their surgical procedure. Responsible antibiotic use protects long-term health and prevents avoidable post-op complications.
What can women do to restore their microbiome after surgery?
Women can restore their microbiome by consuming probiotics, eating fiber-rich foods, and avoiding unnecessary antibiotics. Probiotic-rich foods like yogurt or supplements can help replenish beneficial bacteria. Maintaining a healthy diet and lifestyle promotes a balanced microbiome, strengthening immune defenses and aiding post-surgery recovery.
Surgical procedures are essential but come with risks, especially for women. Contaminated instruments and hospital environments increase the chances of post-op infections. Understanding these risks helps women make better decisions about healthcare providers.
Advocating for proper sterilization, limiting antibiotic use, and following hygiene guidelines reduce infection risks. Staying proactive during recovery ensures a smoother, quicker healing journey. Women must stay informed and ask questions to ensure they receive the best care. Taking proper precautions makes a significant difference in post-operative recovery and long-term health outcomes.
An early PET scan after one cycle of chemotherapy may help predict how aggressive breast cancer responds to treatment, a study suggests.
Research led by The Institute of Cancer Research, London and King’s College London suggests that an early scan taken after one cycle of chemotherapy could help predict how well a patient’s cancer will respond to treatment.
The study focused on patients with triple-negative breast cancer (TNBC), an aggressive form of the disease in which cancer cells lack receptors for the hormones oestrogen and progesterone, as well as the HER2 protein.
Patients with TNBC are usually treated with chemotherapy prior to surgery. While many respond well, residual disease at surgery, typically around six months later, is associated with a significantly poorer prognosis. Identifying people sooner who are unlikely to respond remains a major clinical challenge.
The research explored whether using PET imaging shortly after treatment begins, rather than relying only on MRI scans later in the treatment process, could provide earlier insight into how a patient’s cancer is responding. Twenty-two patients were recruited, with fourteen undergoing FDG-PET scans before treatment and after the first cycle of chemotherapy.
The findings, published in Clinical Cancer Research, showed that changes seen on PET scans after just one cycle of chemotherapy were strongly associated with subsequent response, including whether there was no detectable cancer, known as a complete response, by the end of treatment. Importantly, early PET response showed stronger associations with treatment outcomes than standard mid-treatment MRI scans in this study.
Being able to identify patients who are not responding well at an early stage could allow clinicians to adjust treatment sooner or consider alternative approaches. These findings may also support future strategies to better tailor treatment intensity to individual patients.
The study also compared two types of PET tracers, FDG and FLT, to determine which was most suitable. While both met the study’s technical criteria, FDG-PET was selected for further evaluation due to its better image quality, greater consistency and wider use in clinical practice.
The research also explored how imaging changes after just one cycle of chemotherapy relate to the body’s immune response to treatment. Biopsies taken before and after the first cycle of chemotherapy showed that an increase in immune cells within the tumour was strongly associated with both early PET changes and improved treatment outcomes.
The researchers emphasise that these findings now need to be validated in larger studies. Future work will aim to confirm these results in broader patient groups and explore more accessible imaging approaches, such as ultrasound, alongside PET and MRI.
Sheeba Irshad, professor of cancer immunology at King’s College London and lead of the Breast Cancer Now KCL Research Unit, said:
“In patients who had PET scans both before treatment and after the first cycle, we found that this early scan could predict whether they were likely to achieve a complete response by the end of treatment. These findings highlight the potential of early imaging to guide treatment decisions, and now need to be validated in larger, modern clinical trials.”
Andrew Tutt, professor of breast oncology at The Institute of Cancer Research, London, said:
“Research that helps us determine early who is already benefitting from standard neoadjuvant chemotherapy and who might benefit from clinical trials to find better treatments is vital. This study shows that FDG-PET may have great value in this regard. We hope to be able to design studies that further investigate and validate these findings.”
The study was supported by funding from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust, Breast Cancer Now, Cancer Research UK, and Guy’s and St Thomas’ Charity.
We are excited unveil the three finalists competing for one of the Femtech World Awards’ most coveted honours: the Startup of the Year Award, sponsored by Future Fertility.
This award celebrates an early-stage company making a bold impact in women’s health through innovation, vision and execution.
The winner will be announced at our virtual ceremony on 19 June, with the decision made by a representative from category sponsor Future Fertility.
Congratulations to the shortlist and thank you to everyone who entered or nominated.
Startup of the Year Shortlist
Hello Inside is the first women’s health AI company to turn daily metabolic signals into outcomes women feel and healthcare systems reimburse.
Women’s health has long been under-researched, and current AI benchmarks fail on women’s health questions roughly sixty percent of the time.
Hello Inside built the architecture to close that gap.
Across four years and 12,000+ validated metabolic profiles, three in four women improve at least one symptom within ninety days.
They lose four kilograms in three months, moving from overweight into the healthy range. In a clinical study with Alisa Vitti’s Flo Living, 91.9 per cent reduced PMS burden within sixty days.
U-Ploid is an early-stage biotechnology company tackling one of the most fundamental challenges in fertility care: the sharp, age-related decline in egg quality that limits outcomes across IVF and egg freezing.
While much of the field focuses on improving assessment and selection, U-Ploid is developing a first-in-class therapeutic approach designed to improve egg quality itself by addressing the biological causes of age-related chromosomal errors.
Supported by strong preclinical evidence and now advancing into human studies, U-Ploid combines scientific rigour, regulatory discipline and long-term vision to help redefine what is possible in fertility care.
Gestational diabetes is a strong risk factor for future type 2 diabetes, even in women with normal pre-pregnancy weight, according to a study at the University of Gothenburg.
The researchers call for earlier testing and better follow-up.
“Our results show that gestational diabetes functions as a kind of stress test for the body’s ability to manage blood sugar, and identifies women with a greatly increased risk of future type 2 diabetes”, said Jon Edqvist, PhD and affiliated to research at the University of Gothenburg, and operating room nurse at Sahlgrenska University Hospital.
Gestational diabetes is a special type of diabetes that can affect pregnant women.
The condition is defined as elevated blood sugar levels, without previously known diabetes. Treatment involves self-monitoring of blood sugar, advice on lifestyle habits and, if necessary, medication.
Identifying gestational diabetes is important because the disease increases the risk of complications such as preeclampsia, the need for a cesarean section and high birth weight for the baby.
Those who have had gestational diabetes are also at higher risk of later developing type 2 diabetes.
In the current study, published in eClinicalMedicine, researchers now show that gestational diabetes is a strong indicator of future risk of developing type 2 diabetes, even in women with normal weight before pregnancy.
Elevated risk even with normal weight
The study is based on data from the Medical Birth Registry on just over 1.15 million first-time mothers in Sweden, who gave birth between 1987 and 2019. 16,870 women with confirmed gestational diabetes were compared with age-matched women without the diagnosis. The median follow-up period was nine years.
The results show that women with a BMI of 35 and above, i.e. severe obesity, had an almost tenfold increased risk of developing gestational diabetes compared to women with normal weight.
The risk of subsequent type 2 diabetes also increased with higher BMI, but it was significantly increased even with normal weight, which the researchers describe as particularly worrying.
More follow-up and more studies
The researchers behind the study welcome the recently updated recommendations on gestational diabetes in Sweden, where a higher proportion of pregnant women at increased risk are expected to be offered testing earlier in pregnancy, and if necessary, interventions.
“Diagnostics and care of gestational diabetes have looked very different in different parts of the country,” said Annika Rosengren, professor at the University of Gothenburg.
“There is a need for both improved follow-up after gestational diabetes, and more studies that investigate how such follow-up affects future health and prognosis”
News4 weeks agoWomen’s digital health market set to reach US$5.28 billion in 2026 – report
Insight4 weeks agoWhy the UK’s fertility rate keeps falling – and what it means if you’re trying now
Wellness4 weeks agoWomen’s HealthX unveils Northwell Health, Corewell Health, Biogen & more to headline Chronic Disease stage
Opinion3 weeks agoWhat Maternal Mental Health Month reveals about where postpartum support actually breaks down
Fertility4 weeks agoToxins and climate harms having ‘alarming’ effect on fertility, research warns
News3 weeks agoNIH Grant terminations disproportionately impact minority scientists, research finds
Adolescent health2 weeks agoWUKA brings Period-Positive Pool Party to London Aquatics Centre to keep girls swimming through puberty
Fertility4 weeks agoResearcher explores weight loss jab impact on PCOS